荣昌生物(688331.SH):尚未开始股份回购
Ge Long Hui·2026-01-05 21:47

Core Viewpoint - Rongchang Biologics (688331.SH) has announced that as of December 31, 2025, the company has not yet initiated any share buybacks and will implement buybacks opportunistically based on market conditions [1] Summary by Category - Company Actions - The company has not started any share repurchase program as of the end of 2025 [1] - The implementation of the buyback will depend on market conditions during the repurchase period [1]

REMEGEN-荣昌生物(688331.SH):尚未开始股份回购 - Reportify